Results 221 to 230 of about 16,049,929 (301)

AI empowerment: Establishing the synergy between artificial intelligence and electromagnetic shielding materials research. [PDF]

iScience
Zheng S, Lei J, Xie P, Pan D, Liu C, Shen C.   +5 more
europepmc   +1 more source

Tumor mutational burden as a determinant of metastatic dissemination patterns

Molecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal, Andrea Moreno‐Manuel, Miguel Salvadó‐Pertierra, Cristina Santos‐Vivas, Rebeca Sanz‐Pamplona   +4 more
wiley   +1 more source

L'experiència ELISAVA

Temes de Disseny, 2016
Ismael Almazán, Maria Visa, Francesc Vilaró   +2 more
doaj  

Author Correction: Divalent anion-driven framework regulation in Zr-based halide solid electrolytes for all-solid-state batteries. [PDF]

Nat Commun
Kim JS, Han D, Choe J, Kim Y, Kim HY, Lee S, Seo J, Ham SH, Song YY, Lee CD, Lee J, Kwak H, Kim J, Jung YS, Jung SK, Nam KW, Seo DH.   +16 more
europepmc   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Manufacturability Assessment of Design Decisions for Reducing Material Diversity in Single-Piece and Small-Batch Production. [PDF]

Materials (Basel)
Więcek D, Więcek D, Kuric I.
europepmc   +1 more source

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

Molecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli, Alessio Bevilacqua, Mathias Wenes, Denis Migliorini, Lars van der Veen, Sigrid S Skånland, Giusy Di Conza, Kjetil Taskén   +7 more
wiley   +1 more source

Unlocking toughness in 3D-printed cement through bio-inspired designs: current status and future perspectives. [PDF]

RSC Adv
Fan L, Ji X, Wu C, Zhang W, Tong Y, Wang Q, Song F, Li F, Liu G, Li M.   +9 more
europepmc   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

Molecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon, Dong Young Kim, Yuna Kim, Uk‐Il Kim, Jae‐Sung Kim   +4 more
wiley   +1 more source

Influence of S-PRG-based restorative and adhesive systems on biofilm formation and enamel demineralization in a simulated oral environment. [PDF]

Clin Oral Investig
de Carvalho LF, Badaró MM, Stolf SC, Maske TT, Marques GÁ, da Cunha LM, Longaray JS, Peña CLD, Lund RG, de Andrade JSR.   +9 more
europepmc   +1 more source